StockNYSE · US · USDIndustrials · Security & Protection Services
$ALLE
Allegion plc
Allegion provides security products and access control solutions for commercial, institutional and residential facilities worldwide, serving markets including education, healthcare, government, hospitality, retail, offices and single- and multi-family housing. Its portfolio includes door controls and exit devices, doors and door systems, electronic locks and access control systems, workforce management products, mechanical locks, portable locks, key systems, services and software. Brands include CISA, Interflex, LCN, Schlage, SimonsVoss and Von Duprin. Allegion makes money by selling products and solutions mainly through distribution and retail channels, including specialty distributors, wholesalers, e-commerce platforms and home improvement retailers. Some businesses also sell directly to end-users and provide services such as inspection, maintenance, repair, design and installation. It offers software-as-a-service solutions, including access control and workforce management. Allegion is headquartered in Dublin, Ireland.
Allegion (ALLE) and Johnson Controls (JCI) serve non-residential buildings and data centers, but focus on different products. ALLE stock rose 54% since May 2026, while JCI fell 2.1%. JCI forecasted 11-12% revenue growth for 2027, citing a $23B backlog. ALLE raised its 2026 revenue growth outlook to 5.5%. JCI plans $900M in capex, while ALLE focuses on acquisitions and price increases.
US High Relative Profitability ETF (DUHP) bought $69.9M in Broadcom (AVGO), $33.4M in Micron (MU), and $26.1M in Netflix (NFLX) on Nov. 12, while selling $9.3M in Meta (META). DUHP manages $19.91B in assets, with top holdings in tech and large-cap stocks. Investors may watch for further changes in these positions.
Morgan Stanley kept Allegion's rating at Equal-Weight but increased its price target to $181 from $170, suggesting a 5.6% downside from the last close. Recent analyst targets for Allegion range from $183 to $206.
via TradingView
ALLE sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning ALLE (Allegion plc). Coverage has been balanced: 1 bullish, 0 neutral, and 1 bearish.
Recent ALLE coverage spans financial news, insider activity and earnings.
In the last 30 days, ALLE insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($1.9M). The most active reporter was Kemp Tracy L, SVP-Chief Info. & Digital Ofr, with 1 filing.
AlphAI scores every news story that mentions ALLE with an AI model for sentiment and relevance, and aggregates insider trades from Allegion plc's SEC EDGAR Form 4 filings. Figures refresh continuously.
Allegion (ALLE) and Johnson Controls (JCI) serve non-residential buildings and data centers, but focus on different products. ALLE stock rose 54% since May 2026, while JCI fell 2.1%. JCI forecasted 11-12% revenue growth for 2027, citing a $23B backlog. ALLE raised its 2026 revenue growth outlook to 5.5%. JCI plans $900M in capex, while ALLE focuses on acquisitions and price increases.
US High Relative Profitability ETF (DUHP) bought $69.9M in Broadcom (AVGO), $33.4M in Micron (MU), and $26.1M in Netflix (NFLX) on Nov. 12, while selling $9.3M in Meta (META). DUHP manages $19.91B in assets, with top holdings in tech and large-cap stocks. Investors may watch for further changes in these positions.
Morgan Stanley kept Allegion's rating at Equal-Weight but increased its price target to $181 from $170, suggesting a 5.6% downside from the last close. Recent analyst targets for Allegion range from $183 to $206.
Allegion insiders sold shares. Timothy P. Eckersley sold 6,364 shares at $178.62 each, totaling $1.14M. Kemp Tracy L sold 4,469 shares at $178.805 each, totaling $799,079. Both retained significant holdings.
Analysts updated ratings and price targets for various U.S. companies. Notable changes include downgrades for 10x Genomics (TXG) and upgrades for Allegion (ALLE). Price targets were raised for AbbVie (ABBV), Amgen (AMGN), and others, while cuts were seen in sectors like retail and housing. Analysts favored growth and defensive sectors while showing caution toward consumer-sensitive areas.
Analysts raised Allegion plc's 12-month price target to $191.7, up from $186.4, with a 9% upside based on Oct. 22 closing price. The consensus rating remains 'Buy' among 14 analysts, with 9 Buys and 5 Holds.
ALLE reported Q3 revenue of $1.17B, beating estimates, with adjusted EPS of $2.60 and EBITDA of $308M. Management raised full-year EPS guidance to $9.08. Growth was driven by Americas Non-Residential demand, electronics, and pricing strategies. International segment faced volume weakness. The company completed acquisitions and invested in AI technology.
Analysts made several calls on Friday. Roth initiated Natera and Guardant Health with buy ratings, targeting $475 and growth respectively. PhillipCapital upgraded SpaceX to buy with a $250 price target. Seaport reiterated Nvidia as sell due to competitive pressures. Barclays initiated Rush Street Interactive at overweight. Piper Sandler downgraded Deckers to underweight. Jefferies upgraded MSC Industrial to buy. Citizens initiated Microbot Medical at market outperform.